In vitro activity of tigecycline and comparators (2014–2016) among key WHO ‘priority pathogens’ and longitudinal assessment (2004–2016) of antimicrobial resistance: a report from the T.E.S.T. study
2018 ◽
Vol 52
(4)
◽
pp. 474-484
◽
2021 ◽
pp. 106377
2014 ◽
Vol 69
(7)
◽
pp. 1866-1872
◽
1996 ◽
Vol 57
(13)
◽
pp. 57-64
◽
Keyword(s):
2002 ◽
Vol 50
(suppl 2)
◽
pp. 25-37
◽
2009 ◽
Vol 53
(10)
◽
pp. 4508-4510
◽
2014 ◽
Vol 59
(suppl_6)
◽
pp. S367-S373
◽
Keyword(s):
2005 ◽
Vol 3
(2)
◽
pp. 163-164
2008 ◽
Vol 12
(5)
◽
2018 ◽
Vol Volume 11
◽
pp. 1983-1992
◽
2007 ◽
Vol 29
◽
pp. S521
Keyword(s):